Deadly glycol contamination case delayed again

The trial of Rid Pharmaceuticals' executives for the 2009 incident in which diethylene-glycol-contaminated paracetamol syrup killed 28 children has been delayed for the fifth time. The Dhaka court granted the petition for delay due to health by the chief defendant, Rid managing director Mizanur Rahman. He is accused along with his wife and three other Rid employees of producing the lethal pain reliever. Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.